Correlation Between Sana Biotechnology and Taxus Cardium

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Taxus Cardium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Taxus Cardium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sana Biotechnology and Taxus Cardium Pharmaceuticals, you can compare the effects of market volatilities on Sana Biotechnology and Taxus Cardium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Taxus Cardium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Taxus Cardium.

Diversification Opportunities for Sana Biotechnology and Taxus Cardium

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Sana and Taxus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Taxus Cardium Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taxus Cardium Pharma and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Taxus Cardium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taxus Cardium Pharma has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Taxus Cardium go up and down completely randomly.

Pair Corralation between Sana Biotechnology and Taxus Cardium

If you would invest  560.00  in Sana Biotechnology on November 2, 2024 and sell it today you would lose (211.00) from holding Sana Biotechnology or give up 37.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.97%
ValuesDaily Returns

Sana Biotechnology  vs.  Taxus Cardium Pharmaceuticals

 Performance 
       Timeline  
Sana Biotechnology 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Sana Biotechnology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sana Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.
Taxus Cardium Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Taxus Cardium Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Taxus Cardium is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Sana Biotechnology and Taxus Cardium Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sana Biotechnology and Taxus Cardium

The main advantage of trading using opposite Sana Biotechnology and Taxus Cardium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Taxus Cardium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taxus Cardium will offset losses from the drop in Taxus Cardium's long position.
The idea behind Sana Biotechnology and Taxus Cardium Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities